QUEST DIAGNOSTICS INC

DGX · Mid cap · 0 articles

Financial highlights

Metric	FY 12/31/25	FY 12/31/24	FY 12/31/23	FY 12/31/22	FY 12/31/21
Income Statement
Revenue	$11.0B	$9.9B	$9.3B	$9.9B	$10.8B
Cost of revenue	$7.4B	$6.6B	$6.2B	$6.5B	$6.6B
Selling, general & administrative	$2.0B	$1.8B	$1.6B	$1.9B	$1.7B
Operating income	$1.6B	$1.3B	$1.3B	$1.4B	$2.4B
Interest expense	—	—	$163.0M	$148.0M	$152.0M
Pretax income	$1.3B	$1.2B	$1.1B	$1.2B	$2.6B
Income tax expense	$314.0M	$273.0M	$248.0M	$264.0M	$597.0M
Net income	$992.0M	$871.0M	$854.0M	$946.0M	$2.0B
Balance Sheet
Cash and equivalents	$420.0M	$549.0M	$686.0M	$315.0M	$872.0M
Current assets	$2.4B	$2.4B	$2.4B	$1.9B	$2.7B
Total assets	$16.2B	$16.2B	$14.0B	$12.8B	$13.6B
Current liabilities	$2.3B	$2.2B	$1.8B	$1.6B	$1.8B
Stockholders' equity	$7.2B	$6.8B	$6.3B	$5.9B	$6.4B
Cash Flow Statement
Cash from operations	$1.9B	$1.3B	$1.3B	$1.7B	$2.2B
Depreciation and amortization	$570.0M	$493.0M	$439.0M	$437.0M	$408.0M
Stock-based compensation	$88.0M	$88.0M	$77.0M	$77.0M	$79.0M
Capital expenditure	$527.0M	$425.0M	$408.0M	$404.0M	$403.0M
Free cash flow	$1.4B	$909.0M	$864.0M	$1.3B	$1.8B
Dividends paid	$353.0M	$331.0M	$314.0M	$305.0M	$309.0M
Share repurchases	$450.0M	$151.0M	$275.0M	$1.4B	$2.2B
Impairments	$0	$0	$0	$0	—

Shares outstanding 110.7M · Free float 99.5%

Annual filing data through FY ended December 31, 2025; float as of July 11, 2026.